As on Tuesday, Baxter International Inc (NYSE: BAX) started slowly as it slid -0.34% to $29.08, before settling in for the price of $29.18 at the close. Taking a more long-term approach, BAX posted a 52-week range of $28.62-$44.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 6.04% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is -29.69%. This publicly-traded company’s shares outstanding now amounts to $510.46 million, simultaneously with a float of $506.58 million. The organization now has a market capitalization sitting at $14.80 billion. At the time of writing, stock’s 50-day Moving Average stood at $33.46, while the 200-day Moving Average is $36.29.
Baxter International Inc (BAX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Instruments & Supplies industry. Baxter International Inc’s current insider ownership accounts for 0.79%, in contrast to 93.73% institutional ownership.
Baxter International Inc (BAX) Earnings and Revenue Records
Baxter International Inc’s EPS decrease for this current 12-month fiscal period is -29.69% and is forecasted to reach 2.48 in the upcoming year.
Baxter International Inc (NYSE: BAX) Trading Performance Indicators
Let’s observe the current performance indicators for Baxter International Inc (BAX). It’s Quick Ratio in the last reported quarter now stands at 1.09. The Stock has managed to achieve an average true range (ATR) of 0.78. Alongside those numbers, its PE Ratio stands at $126.82, and its Beta score is 0.59. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.06. Similarly, its price to free cash flow for trailing twelve months is now 26.52.
In the same vein, BAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.23, a figure that is expected to reach 0.52 in the next quarter, and analysts are predicting that it will be 2.48 at the market close of one year from today.
Technical Analysis of Baxter International Inc (BAX)
Through scrutinizing the latest numbers posted by the [Baxter International Inc, BAX], it can be observed that its last 5-days Average volume of 6.36 million was better the volume of 4.17 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 21.12% While, its Average True Range was 0.77.
Raw Stochastic average of Baxter International Inc (BAX) in the period of the previous 100 days is set at 3.91%, which indicates a major fall in contrast to 10.30% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 21.99% that was lower than 28.38% volatility it exhibited in the past 100-days period.
